Health regulatory communications of well-established safety-related pharmacogenomics associations in six developed countries: an evaluation of alignment.

Abstract excerpt

Recommendations on genetic testing are typically conveyed by drug regulatory authorities through drug labels, which are legal requirements for market authorization of drugs. We conducted a cross-sectional study of drug labels focusing on three crucial aspects of regulatory pharmacogenomics communications: (i) intent; (ii) interpretation in the local context; and (iii) implications of the genetic information....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Breast Feeding
• Share to Consensus
• Share to Drug-Related Side Effects and Adverse Reactions